CBD of Denver Overview
Latest ROE for CBD of Denver: 7.85% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow7.85%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for CBDD is 7.85%. That is below the sector sector average of 11.75%. Investors often review this figure alongside CBD of Denver's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, CBDD currently prints 7.85% for ROE, while the sector average sits near 11.75%. That is roughly 33.2% below the sector mean. Large gaps often invite a closer look at CBD of Denver's growth, margins, and balance sheet.
Return on Equity shows how effectively CBD of Denver converts resources into returns. At 7.85%, CBDD may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting CBDD's ROE (7.85%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
